Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Other Operating Expenses (2021 - 2025)

Senti Biosciences has reported Other Operating Expenses over the past 4 years, most recently at $5.1 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $5.1 million for Q4 2025, up 1514.06% from a year ago — trailing twelve months through Dec 2025 was $5.1 million (up 1514.06% YoY), and the annual figure for FY2025 was $5.1 million, up 1514.06%.
  • Other Operating Expenses for Q4 2025 was $5.1 million at Senti Biosciences, up from $313000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for SNTI hit a ceiling of $25.7 million in Q3 2023 and a floor of $1178.0 in Q1 2021.
  • Median Other Operating Expenses over the past 4 years was $313000.0 (2024), compared with a mean of $6.3 million.
  • Biggest five-year swings in Other Operating Expenses: grew 15.5% in 2024 and later skyrocketed 1514.06% in 2025.
  • Senti Biosciences' Other Operating Expenses stood at $1178.0 in 2021, then skyrocketed by 22905.09% to $271000.0 in 2023, then rose by 15.5% to $313000.0 in 2024, then soared by 1514.06% to $5.1 million in 2025.
  • The last three reported values for Other Operating Expenses were $5.1 million (Q4 2025), $313000.0 (Q4 2024), and $271000.0 (Q4 2023) per Business Quant data.